Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab

Detalles Bibliográficos
Autores principales: VandeVrede, Lawren, La Joie, Renaud, Horiki, Sheena, Mundada, Nidhi S., Koestler, Mary, Hwang, Ji-Hye, Ljubenkov, Peter A., Rojas, Julio C., Rabinovici, Gil D., Boxer, Adam L., Seeley, William W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564667/
https://www.ncbi.nlm.nih.gov/pubmed/37725166
http://dx.doi.org/10.1007/s00401-023-02631-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564667/
https://www.ncbi.nlm.nih.gov/pubmed/37725166
http://dx.doi.org/10.1007/s00401-023-02631-8

Ejemplares similares